Molecules/TORIPALIMAB

TORIPALIMAB

Molecular Identity

AntibodyApprovedFirst approved 2023

Mechanism of action: Programmed cell death protein 1 antagonist

Molecular Formula

0.00

Molecular Weight

g/mol

ANTI-PD-I MAB-SHANGHAI JUNSHICHS-007JS-001JS001LOQTORZITAB-001TAB001TERIPRIZUMABTORIPALIMABTORIPALIMAB-TPZITREPRIZUMABTRIPLEITRIUMABTRIPRIZUMABTUOYI

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to TORIPALIMAB

Loading drug network...